The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development

C. Ragu; S. Boukour; G. Elain; O. Wagner-Ballon; H. Raslova; N. Debili; E. N. Olson; D. Daegelen; W. Vainchenker; O. A. Bernard; V. Penard-Lacronique

doi:10.1038/leu.2010.80

The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development

C. Ragu, S. Boukour, G. Elain, O. Wagner-Ballon, H. Raslova, N. Debili, E. N. Olson, D. Daegelen, W. Vainchenker, O. A. Bernard, V. Penard-Lacronique

Research output: Contribution to journal › Letter › peer-review

28 Citations (Scopus)

Original language	English
Pages (from-to)	1227-1230
Number of pages	4
Journal	Leukemia
Volume	24
Issue number	6
DOIs	https://doi.org/10.1038/leu.2010.80
Publication status	Published - 1 Jun 2010

Access to Document

10.1038/leu.2010.80

Cite this

@article{f26673dfdd704103a6a38cc5eb67b697,

title = "The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development",

author = "C. Ragu and S. Boukour and G. Elain and O. Wagner-Ballon and H. Raslova and N. Debili and Olson, {E. N.} and D. Daegelen and W. Vainchenker and Bernard, {O. A.} and V. Penard-Lacronique",

note = "Funding Information: We thank L Gilles for technical advices. J Di Santo (Institut Pasteur, Paris, France) provided the Mx1-Cre mice. Funding from INSERM, ARC, LNCC ({\'e}quipes labelis{\'e}es OAB and WV) and INCa supported this work. CR was funded by a fellowship from the FRM and the SFH. GE was funded by an ARC/INCa grant. SB is funded by a fellowship from the INCa.",

year = "2010",

month = jun,

day = "1",

doi = "10.1038/leu.2010.80",

language = "English",

volume = "24",

pages = "1227--1230",

journal = "Leukemia",

issn = "0887-6924",

number = "6",

}

TY - JOUR

T1 - The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development

AU - Ragu, C.

AU - Boukour, S.

AU - Elain, G.

AU - Wagner-Ballon, O.

AU - Raslova, H.

AU - Debili, N.

AU - Olson, E. N.

AU - Daegelen, D.

AU - Vainchenker, W.

AU - Bernard, O. A.

AU - Penard-Lacronique, V.

N1 - Funding Information: We thank L Gilles for technical advices. J Di Santo (Institut Pasteur, Paris, France) provided the Mx1-Cre mice. Funding from INSERM, ARC, LNCC (équipes labelisées OAB and WV) and INCa supported this work. CR was funded by a fellowship from the FRM and the SFH. GE was funded by an ARC/INCa grant. SB is funded by a fellowship from the INCa.

PY - 2010/6/1

Y1 - 2010/6/1

UR - http://www.scopus.com/inward/record.url?scp=77954597084&partnerID=8YFLogxK

U2 - 10.1038/leu.2010.80

DO - 10.1038/leu.2010.80

M3 - Letter

C2 - 20428204

AN - SCOPUS:77954597084

SN - 0887-6924

VL - 24

SP - 1227

EP - 1230

JO - Leukemia

JF - Leukemia

IS - 6

ER -

The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development

Access to Document

Other files and links

Cite this